$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 (COVID-19) in a Human Cell Line […]

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals’ Brilacidin Reduces Viral Titer of SARS-CoV-2 (COVID-19) by 75 percent After Only 1 Hour of Preincubation in In Vitro S […]

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2 (COVID-19) in Primary Human Immune Cells to be Studied at Leading Public H […]

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
Copyright 2019 – OTC Markets Group Inc.

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Screening of 11,552 Compounds Identifies Innovation Pharmaceuticals’ Brilacidin as One of the Most Promising Potential Inhibitors of the Novel C […]

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals in Discussions to Advance Brilacidin into Human Trials Against COVID-19
Copyright 2019 – OTC Markets Group Inc.

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
C […]

$IPIX #OTCQB Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Brilacidin to be Researched as Possible Novel Coronavirus (COVID-19) Vaccine; Brilacidin Now Being Tested as Drug and […]